In 2024, tuberculosis mortality among men in the UK is forecasted to be stable, standing at 400.0 per hundred men consistently through 2028. This forecast implies no variation in year-on-year terms over the next five years, as figures remain unchanged from previous reports.
In 2023, the data served as a baseline for deriving this forecast, which demonstrates an ongoing effort in maintaining control measures against tuberculosis. Therefore, between 2024 and 2028, no Compound Annual Growth Rate (CAGR) is observed, indicating a stable situation concerning tuberculosis mortality.
Future trends to watch for:
- Developments in treatment and prevention strategies that might influence the stability in mortality rates.
- Any potential impact of healthcare policy changes or advancements in medical technology.
- Possible emergence of drug-resistant tuberculosis strains affecting mortality rates.
